| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 338 | 27.995 | 27.362 | 25.147 | 32.791 | 31.884 |
| Total Income - EUR | - | - | - | - | 338 | 27.995 | 27.362 | 25.147 | 32.791 | 31.884 |
| Total Expenses - EUR | - | - | - | - | 436 | 5.723 | 17.297 | 19.977 | 32.449 | 44.930 |
| Gross Profit/Loss - EUR | - | - | - | - | -99 | 22.272 | 10.065 | 5.171 | 342 | -13.046 |
| Net Profit/Loss - EUR | - | - | - | - | -109 | 21.560 | 9.615 | 4.638 | 14 | -14.003 |
| Employees | - | - | - | - | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Adanmedix S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 17.527 | 12.242 | 7.368 | 2.449 | 0 |
| Current Assets | - | - | - | - | 405 | 16.183 | 27.530 | 21.262 | 20.198 | 9.791 |
| Inventories | - | - | - | - | 0 | 56 | 55 | 55 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 953 | 933 | 0 | 10.108 | 0 |
| Cash | - | - | - | - | 405 | 15.174 | 26.543 | 21.207 | 10.090 | 9.791 |
| Shareholders Funds | - | - | - | - | -67 | 21.495 | 30.633 | 4.678 | 54 | -13.949 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 471 | 12.216 | 9.139 | 23.951 | 22.592 | 23.739 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Adanmedix S.r.l.